English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report

Kim, M., Eleftheriou, A., Ravotto, L., Weber, B., Rivlin, M., Navon, G., et al. (2022). What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report. Magnetic Resonance Materials in Physics, Biology and Medicine, 35(1), 87-104. doi:10.1007/s10334-021-00994-1.

Item is

Basic

show hide
Genre: Journal Article

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Kim, M, Author
Eleftheriou, A, Author
Ravotto, L, Author
Weber, B, Author
Rivlin, M, Author
Navon, G, Author
Capozza, M, Author
Anemone, A, Author
Longo, DL, Author
Aime, S, Author
Zaiss, M1, 2, Author              
Herz, K1, 2, Author              
Deshmane, A1, 2, Author              
Lindig, T1, 2, Author              
Bender, B, Author              
Golay, X, Author
Affiliations:
1Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497796              
2Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497794              

Content

show
hide
Free keywords: -
 Abstract: Cancer is one of the most devastating diseases that the world is currently facing, accounting for 10 million deaths in 2020 (WHO). In the last two decades, advanced medical imaging has played an ever more important role in the early detection of the disease, as it increases the chances of survival and the potential for full recovery. To date, dynamic glucose-enhanced (DGE) MRI using glucose-based chemical exchange saturation transfer (glucoCEST) has demonstrated the sensitivity to detect both D-glucose and glucose analogs, such as 3-oxy-methyl-D-glucose (3OMG) uptake in tumors. As one of the recent international efforts aiming at pushing the boundaries of translation of the DGE MRI technique into clinical practice, a multidisciplinary team of eight partners came together to form the "glucoCEST Imaging of Neoplastic Tumors (GLINT)" consortium, funded by the Horizon 2020 European Commission. This paper summarizes the progress made to date both by these groups and others in increasing our knowledge of the underlying mechanisms related to this technique as well as translating it into clinical practice.

Details

show
hide
Language(s):
 Dates: 2022-012022-02
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: DOI: 10.1007/s10334-021-00994-1
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Magnetic Resonance Materials in Physics, Biology and Medicine
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Amsterdam : No longer published by Elsevier
Pages: - Volume / Issue: 35 (1) Sequence Number: - Start / End Page: 87 - 104 Identifier: ISSN: 0968-5243
CoNE: https://pure.mpg.de/cone/journals/resource/954926245532